Far from being a simple end of menstruation, menopause marks a deep biological transition with significant long-term implications for women's health.
Menopause and the leap forward in women's health
Far from being a simple end of menstruation, menopause marks a deep biological transition with significant long-term implications for women's health. For years, it has been a chapter often minimized, focused on managing uncomfortable symptoms. However, a recent paradigm shift in Hormone Therapy (HT) is redefining how we understand and approach this stage, offering new hope for women's longevity.
At Progevita, where we focus on predictive medicine and lifespan optimization, this progress is fundamental. It's not only about relieving hot flashes, but about protecting a woman's integral health against the challenges imposed by hormonal decline.
If you want a version more focused on healthspan, muscle, bone, and cardiovascular risk, here is our guide on menopause and longevity.
What does the new approval of HT mean?
Hormone Therapy (HT), which involves supplementation with estrogen and/or progesterone, is not new. However, past decades were marked by controversy and misunderstanding, especially after the results of studies such as the Women's Health Initiative (WHI) in the early 2000s. The initial, often alarmist interpretation led many women and healthcare professionals to avoid it.
A few months ago, thanks to a thorough re-evaluation of the data and the emergence of new formulations (bioidentical hormones), routes of administration, and a focus on the window of opportunity for initiation, the scientific community (FDA) reached a more nuanced consensus: HT is safe and effective for many women, especially when started early in perimenopause or early menopause.
This "new advance" is, in fact, a reaffirmation based on updated evidence, validating HT as a powerful tool in disease prevention and quality-of-life improvement.
Beyond symptoms: HT's impact on women's longevity
The hormonal decline associated with menopause is a catalyst for a cascade of systemic changes that dramatically affect women's health. This is where HT emerges as a true pillar of longevity medicine:
Bone health: the shield against osteoporosis
The decline in estrogen accelerates loss of bone density. An estimated 80% of people with osteoporosis are women, and half of them will suffer a related fracture after age 50 (NIH). HT is one of the most effective strategies to prevent this bone loss, reducing the risk of spine and hip fractures by 20-30% when started within the appropriate window (The North American Menopause Society).
Cardiovascular health: protecting the female heart
Before menopause, estrogens offer significant cardiovascular protection. After menopause, a woman's risk of heart disease equals and even surpasses a man's. HT, when started within the first 10 years of menopause (the "window of opportunity"), has been shown to reduce coronary disease risk and maintain healthy vascular function (Manson et al., 2013). Cardiovascular disease is estimated to be the leading cause of death in postmenopausal women.
Cognitive health: a clear and protected mind
Many women experience "brain fog" and memory difficulties during perimenopause. Emerging research suggests HT may have a neuroprotective role, especially against cognitive decline and certain forms of dementia if started early, although this area remains under intense research.
Quality of life and general wellbeing
Beyond vasomotor symptoms (hot flashes, night sweats), HT improves sleep, mood, vaginal dryness, and sexual function—fundamental aspects of a full and satisfying longevity.
A personalized approach guided by a specialist
It is crucial to understand that HT is not a universal solution. Its indication, hormone type, dose, and route of administration must be strictly individualized. Factors such as personal medical history (breast cancer antecedents, thrombosis, etc.), the age at which perimenopause started, and the time elapsed since then are decisive. Hormone therapy is complemented by other treatments such as vaginal ozone therapy, which can relieve the symptoms of genitourinary syndrome of menopause. Measuring longevity biomarkers such as the hormonal profile, hsCRP, and body composition allows us to personalize the approach and assess therapy response.
This is where the incalculable value of precision medicine and expert guidance lies. At Progevita, our longevity-medicine specialists work with an integrative approach. We do not see menopause in isolation, but as part of your complete biological health map.
Your longevity is not an accident; it is a design. Menopause is a critical stage where informed decisions, made with expert support, can make the difference between an accelerated biological decline and a decade of full, healthy life.
Empowering women for an active longevity
The reaffirmation of Hormone Therapy as a safe and effective option represents a milestone in women's medicine and in longevity. At Progevita, we embrace these advances to empower our patients. Menopause does not have to be the beginning of decline; with appropriate medical support and a proactive strategy, it can be the start of a new phase of prolonged vitality and wellbeing.